{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:23Z","timestamp":1787065223775,"version":"build-2736575974"},"reference-count":89,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,6,25]]},"DOI":"10.3233\/jad-150140","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T06:21:10Z","timestamp":1435299670000},"page":"777-790","source":"Crossref","is-referenced-by-count":96,"title":["Associations between Homocysteine, Folic\u00a0Acid, Vitamin B12 and Alzheimer\u2019s Disease: Insights from Meta-Analyses"],"prefix":"10.1177","volume":"46","author":[{"given":"Liang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Fang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150140_ref1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150140_ref2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: The aging, demographics, and memory study","volume":"29","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-150140_ref3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-150140_ref4","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150140_ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-150140_ref6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150140_ref7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(03)00438-1","article-title":"Homocysteine and Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150140_ref8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1567205052772704","article-title":"Biochemical markers and risk factors of Alzheimer\u2019s disease","volume":"2","author":"Flirski","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-150140_ref9","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150140_ref10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","article-title":"Is hyperhomocysteinemia an Alzheimer\u2019s disease (AD) risk factor, an AD marker, or neither?","volume":"32","author":"Zhuo","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-150140_ref11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","article-title":"Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease","volume":"55","author":"Clarke","year":"1998","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150140_ref12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s007020070010","article-title":"Hyperhomocysteinemia in dementia","volume":"107","author":"Leblhuber","year":"2000","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150140_ref13","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0047-6374(01)00307-4","article-title":"Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: A study in an Italian population with dementia","volume":"122","author":"Bottiglieri","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-150140_ref14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000052822","article-title":"Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer\u2019s dementia. A case-control study","volume":"47","author":"Postiglione","year":"2001","journal-title":"Gerontology"},{"key":"10.3233\/JAD-150140_ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000058327","article-title":"Relation between plasma homocysteine and Alzheimer\u2019s disease","volume":"14","author":"Nilsson","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150140_ref16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archneur.59.5.787","article-title":"Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease","volume":"59","author":"Hogervorst","year":"2002","journal-title":"Arch Neural"},{"key":"10.3233\/JAD-150140_ref17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.58.10.1471","article-title":"Homocysteine, vitamin B6, and vascular disease in AD patients","volume":"58","author":"Miller","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-150140_ref18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(01)00327-X","article-title":"The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"23","author":"Selley","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150140_ref19","first-page":"160","article-title":"Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging","volume":"7","author":"Mizrahi","year":"2003","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-150140_ref20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000072812","article-title":"Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia","volume":"16","author":"Nagga","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150140_ref21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000070677","article-title":"Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer\u2019s disease and mild cognitive impairment","volume":"16","author":"Religa","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150140_ref22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(03)00007-1","article-title":"Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer\u2019s disease","volume":"24","author":"Selley","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150140_ref23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.archger.2004.04.027","article-title":"Homocysteine in Alzheimer disease and vascular dementia","volume":"9","author":"Gallucci","year":"2004","journal-title":"Arch Gerontol Geriatr Suppl"},{"key":"10.3233\/JAD-150140_ref24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF03033443","article-title":"Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer\u2019s disease patients and in Parkinson\u2019s disease patients","volume":"6","author":"Genedani","year":"2004","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-150140_ref25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2004.08.011","article-title":"Plasma homocysteine, vitamin B12 and folate in Alzheimer\u2019s patients and healthy Arabs in Israel","volume":"227","author":"Mizrahi","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-150140_ref26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/80.1.114","article-title":"Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia","volume":"80","author":"Quadri","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-150140_ref27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00001756-200404090-00025","article-title":"Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer\u2019s disease","volume":"15","author":"Anello","year":"2004","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-150140_ref28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejim.2004.05.008","article-title":"Helicobacter pylori and Alzheimer\u2019s disease: A possible link","volume":"15","author":"Malaguarnera","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.3233\/JAD-150140_ref29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cccn.2005.03.049","article-title":"Homocysteine, vitamin B 12 and folate in Alzheimer\u2019s and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition","volume":"359","author":"Dominguez","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-150140_ref30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10522-005-2622-3","article-title":"A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls","volume":"6","author":"Folin","year":"2005","journal-title":"Biogerontology"},{"key":"10.3233\/JAD-150140_ref31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neurobiolaging.2004.07.003","article-title":"Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients","volume":"26","author":"Guidi","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150140_ref32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/03610730590948221","article-title":"Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer\u2019s disease","volume":"31","author":"Asita De Silva","year":"2005","journal-title":"Exp Aging Res"},{"key":"10.3233\/JAD-150140_ref33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1515\/CCLM.2005.191","article-title":"Homocysteine and B vitamins in mild cognitive impairment and dementia","volume":"43","author":"Quadri","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-150140_ref34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1533317506289282","article-title":"The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer\u2019s disease in mild cognitive impairment: A 6-year follow-up study","volume":"21","author":"Annerbo","year":"2006","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-150140_ref35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1590\/S0004-282X2006000600010","article-title":"Alzheimer\u2019s disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms","volume":"64","author":"da Silva","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"10.3233\/JAD-150140_ref36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000110641","article-title":"Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer\u2019s disease and mild cognitive impairment patients","volume":"14","author":"Hernanz","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.3233\/JAD-150140_ref37","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.neurobiolaging.2006.08.003","article-title":"A metabolic link between S adenosylhomocysteine and polyunsaturatcd fatty acid metabolism in Alzheimer\u2019s disease","volume":"28","author":"Selley","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150140_ref38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clinbiochem.2007.04.007","article-title":"Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease","volume":"40","author":"Koseoglu","year":"2007","journal-title":"Clin Biochem"},{"key":"10.3233\/JAD-150140_ref39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1159\/000129696","article-title":"CSF\/serum folate gradient: Physiology and determinants with special reference to dementia","volume":"25","author":"Hagnelius","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150140_ref40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00702-009-0325-7","article-title":"Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer\u2019s disease","volume":"116","author":"Lepara","year":"2009","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150140_ref41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1024\/0300-9831.79.3.166","article-title":"Fasting and post-methionine homocysteine levels in Alzheimer\u2019s disease and vascular dementia","volume":"79","author":"Villa","year":"2009","journal-title":"Int Vitam Nutr Res"},{"key":"10.3233\/JAD-150140_ref42","first-page":"181","article-title":"Serum levels of homocysteine, vitamin B12, and folic acid in patients with Alzheimer\u2019s disease","volume":"34","author":"Karimi","year":"2009","journal-title":"Iran J Med Sci"},{"key":"10.3233\/JAD-150140_ref43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000309657","article-title":"S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"7","author":"Linnebank","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-150140_ref44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000326301","article-title":"Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer\u2019s disease or dementia: A case control study","volume":"65","author":"Smach","year":"2011","journal-title":"Eur Neurol"},{"key":"10.3233\/JAD-150140_ref45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.55782\/ane-2012-1911","article-title":"Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer\u2019s disease","volume":"72","author":"Czapski","year":"2012","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.3233\/JAD-150140_ref46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-2012-121345","article-title":"Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: A cross-sectional survey","volume":"33","author":"Kim","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150140_ref47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2013.11.041","article-title":"Oxidative balance, homocysteine, and uric acid levels in older patients with late onset Alzheimer\u2019s disease or vascular dementia","volume":"337","author":"Cervellati","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-150140_ref48","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.lfs.2005.02.014","article-title":"Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"77","author":"Isobe","year":"2005","journal-title":"Life Sci"},{"key":"10.3233\/JAD-150140_ref49","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/jnnp.2004.056119","article-title":"Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: Relation with age and Alzheimer\u2019s disease","volume":"76","author":"Serot","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-150140_ref50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-2009-1187","article-title":"Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer\u2019s disease","volume":"18","author":"Popp","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150140_ref51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03159958","article-title":"Platelet MAO-B activity and vitamin B12 in old age dementias","volume":"16","author":"Parnetti","year":"1992","journal-title":"Mol Chem Neuropathol"},{"key":"10.3233\/JAD-150140_ref52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0404.1992.tb04044.x","article-title":"Vitamin B12 in CSF: Reduced CSF\/serum B12 ratio in demented men","volume":"85","author":"Regland","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-150140_ref53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/gerona\/52A.2.M76","article-title":"Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer\u2019s disease?","volume":"52","author":"Joosten","year":"1997","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-150140_ref54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0047-6374(00)00221-9","article-title":"Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment","volume":"121","author":"Ravaglia","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-150140_ref55","first-page":"155","article-title":"The interaction of serum folate and estradiol levels in Alzheimer\u2019s disease","volume":"23","author":"Hogervorst","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"10.3233\/JAD-150140_ref56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcn\/80.2.483","article-title":"Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease","volume":"80","author":"Ravaglia","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-150140_ref57","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000183063.99107.5c","article-title":"Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease","volume":"65","author":"Irizarry","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-150140_ref58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cccn.2005.03.049","article-title":"Homocysteine, vitamin B 12 and folate in Alzheimer\u2019s and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition","volume":"359","author":"Dominguez","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-150140_ref59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2007.04.060","article-title":"Serum folate concentrations in patients with cortical and subcortical dementias","volume":"420","author":"Lovati","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150140_ref60","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.clinbiochem.2008.03.015","article-title":"Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?","volume":"41","author":"Galimberti","year":"2008","journal-title":"Clin Biochem"},{"key":"10.3233\/JAD-150140_ref61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0972-2327.74193","article-title":"Role of vitamin B (12), folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population","volume":"13","author":"Agarwal","year":"2010","journal-title":"Ann Indian Acad Neurol"},{"key":"10.3233\/JAD-150140_ref62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2010.08.050","article-title":"Effect of an antioxidant drink on homocysteine levels in Alzheimer\u2019s patients","volume":"299","author":"Morillas-Ruiz","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-150140_ref63","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2011-110752","article-title":"Homocysteine, vitamin B12, and folic acid levels in Alzheimer\u2019s disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle Study","volume":"27","author":"Faux","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150140_ref64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s007020170100","article-title":"CSF-folate levels are decreased in late-onset AD patients","volume":"108","author":"Serot","year":"2001","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150140_ref65","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1600-0404.1993.tb04140.x","article-title":"Serum cobalamin and methylmalonic acid in Alzheimer dementia","volume":"87","author":"Kristensen","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-150140_ref66","first-page":"407","article-title":"Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease","volume":"8","author":"Glaso","year":"2004","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-150140_ref67","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-150140_ref68","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.STR.0000032550.90046.38","article-title":"Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland","volume":"33","author":"McIIroy","year":"2002","journal-title":"Stroke"},{"key":"10.3233\/JAD-150140_ref69","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(04)00878-6","article-title":"Dietary factors and Alzheimer\u2019s disease","volume":"3","author":"Luchsinger","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150140_ref70","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","article-title":"Homocysteine and folate as risk factors for dementia and Alzheimer disease","volume":"82","author":"Ravaglia","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-150140_ref71","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/ajcn\/85.2.511","article-title":"Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging","volume":"85","author":"Haan","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-150140_ref72","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1212\/WNL.56.9.1188","article-title":"Vitamin B(12) and folate in relation to the development of Alzheimer\u2019s disease","volume":"56","author":"Wang","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-150140_ref73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000057701","article-title":"Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons","volume":"13","author":"Maxwell","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150140_ref74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000089515","article-title":"Conversion of mild cognitive impairment to dementia: Predictive role of mild cognitive impairment subtypes and vascular risk factors","volume":"21","author":"Ravaglia","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150140_ref75","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-2012-121378","article-title":"Hyperhomocysteinemia in Alzheimer\u2019s disease: The hen and the egg?","volume":"33","author":"Farkas","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150140_ref76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-150140_ref77","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-2009-1013","article-title":"Oxidative stress in diabetes and Alzheimer\u2019s disease","volume":"16","author":"Reddy","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150140_ref78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.101.5.485","article-title":"Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults","volume":"101","author":"Chao","year":"2000","journal-title":"Circulation"},{"key":"10.3233\/JAD-150140_ref79","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-150140_ref80","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer\u2019s disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic Res"},{"key":"10.3233\/JAD-150140_ref81","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150140_ref82","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1515\/CCLM.2001.113","article-title":"Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?","volume":"39","author":"Fuchs","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-150140_ref83","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.70.3.419","article-title":"Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress?","volume":"70","author":"Widner","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-150140_ref84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00019052-200102000-00015","article-title":"Homocysteine and stroke","volume":"14","author":"Hankey","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JAD-150140_ref85","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2353\/ajpath.2009.081036","article-title":"Hyperhomocysteinemia increases beta amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain","volume":"174","author":"Zhang","year":"2009","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-150140_ref86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00702-006-0564-9","article-title":"Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer\u2019s disease","volume":"114","author":"Agnati","year":"2007","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150140_ref87","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150140_ref88","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.pnpbp.2005.06.026","article-title":"Homocysteine and brain atrophy","volume":"29","author":"Sachdev","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-150140_ref89","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.58.10.1539","article-title":"Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals","volume":"58","author":"Sachdev","year":"2002","journal-title":"Neurology"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:19Z","timestamp":1777370539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,25]]},"references-count":89,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-150140","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,25]]}}}